Pharmacy Quality Assurance Commission adopts emergency rules to reduce burdens on practitioners prescribing Schedule II substances.
The Pharmacy Quality Assurance Commission adopted emergency rules to reduce burdens on practitioners prescribing Schedule II substances during the COVID-19 outbreak. The emergency rule amends WAC 246-887-020 and increases the duration of time a practitioner has to deliver a signed prescription when authorizing an emergency prescription of a Schedule II substance to the pharmacy from seven days to fifteen days. The emergency redefines what is a “signed prescription.”
Emergency rules filed on April 21, 2020, under WSR 20-09-133 are effective immediately and will remain enforce for 120 days.